Steffi Oesterreich

ORCID: 0000-0002-2537-6923 · 6 papers in corpus
preprint 2024
·doi:10.1158/2767-9764.25012804

BioID setup and proof-of-concept

2024
Cancer research communications ·doi:10.1158/2767-9764.crc-23-0275

Wnt ligand WNT4 is critical in female reproductive tissue development, with WNT4 dysregulation linked to related pathologies including breast cancer (invasive lobular carcinoma, ILC) and gynecologic cancers. WNT4 signaling in these contexts…

article 2018
·doi:10.1158/1557-3265.ovca17-b23

Abstract Objectives: To investigate changes in estrogen receptor–alpha (ERα) signaling during the progression of endometriosis to endometriosis-associated ovarian cancer (EAOC) as a putative driver of malignant transformation. Methods: We p…

article 2018
Hormones & cancer ·doi:10.1007/s12672-018-0350-9

To investigate changes in estrogen receptor alpha (ERα) signaling during progression of endometriosis to endometriosis-associated ovarian cancer (EAOC) as a driver of malignant transformation. We procured tissue samples of normal endometriu…

article 2016
·doi:10.1016/j.ygyno.2016.04.305
2012
Endocrine-related cancer ·doi:10.1530/erc-12-0175

Ovarian cancer is the sixth most common cancer worldwide among women in developed countries and the most lethal of all gynecologic malignancies. There is a critical need for the introduction of targeted therapies to improve outcome. Epidemi…